CIK 0000842023 · Large accelerated filer
BIO-TECHNE Corp
Sign in to watch- Ticker
- TECH
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411427402
- Phone
- 612-379-8854
- Business address
- 614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
- Former names
- TECHNE CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-10-26 | Kummeth Charles R. Chief Executive Officer | Grant or award · Stock Options (Right to buy) | +117,342 | 117,342 | ||
| 2017-10-26 | Kummeth Charles R. Chief Executive Officer | Grant or award · Stock Options (Right to buy) | +78,228 | 78,228 | ||
| 2017-10-26 | Seth Alpna Director | Grant or award | +739 | 739 | ||
| 2017-10-26 | Seth Alpna Director | Grant or award · Stock Options (Right to buy) | +3,125 | 3,125 | ||
| 2017-10-26 | STEER RANDOLPH C Director | Grant or award | +739 | 3,712 | ||
| 2017-10-26 | STEER RANDOLPH C Director | Grant or award · Stock Option (right to buy) | +3,125 | 3,125 | ||
| 2017-10-26 | Bazan J. Fernando Chief Technical Officer | Grant or award · Restricted Stock Units | +1,649 | 1,649 | ||
| 2017-10-26 | Bazan J. Fernando Chief Technical Officer | Grant or award · Stock Options (Right to buy) | +9,089 | 9,089 | ||
| 2017-10-26 | Bazan J. Fernando Chief Technical Officer | Grant or award · Stock Options (Right to buy) | +12,119 | 12,119 | ||
| 2017-10-26 | BAUMGARTNER ROBERT V Director | Grant or award | +739 | 7,712 | ||
| 2017-10-26 | BAUMGARTNER ROBERT V Director | Grant or award · Stock Option (right to buy) | +3,125 | 3,125 | ||
| 2017-10-26 | Furlow Brenda S. SVP - General Counsel | Grant or award · Restricted Stock Units | +1,724 | 1,724 | ||
| 2017-10-26 | Furlow Brenda S. SVP - General Counsel | Grant or award · Stock Options (Right to buy) | +9,503 | 9,503 | ||
| 2017-10-26 | Furlow Brenda S. SVP - General Counsel | Grant or award · Stock Options (Right to buy) | +12,670 | 12,670 | ||
| 2017-10-26 | Gavin Robert M. Sen. VP Protein Platforms | Grant or award · Restricted Stock Units | +1,949 | 1,949 | ||
| 2017-10-26 | Gavin Robert M. Sen. VP Protein Platforms | Grant or award · Stock Options (Right to buy) | +10,742 | 10,742 | ||
| 2017-10-26 | Gavin Robert M. Sen. VP Protein Platforms | Grant or award · Stock Options (Right to buy) | +14,323 | 14,323 | ||
| 2017-10-26 | Gould Kevin S SVP Clinical Controls | Grant or award · Restricted Stock Units | +1,949 | 1,949 | ||
| 2017-10-26 | Gould Kevin S SVP Clinical Controls | Grant or award · Stock Options (Right to buy) | +10,742 | 10,742 | ||
| 2017-10-26 | Gould Kevin S SVP Clinical Controls | Grant or award · Stock Options (Right to buy) | +14,323 | 14,323 |
Page 57 of 64 · 1,274 trades